When it comes to the effects of low-grade inflammation in the brain and how this might cause the mental health conditions it has been linked to (which include major depression, bipolar, OCD, schizophrenia and the cognitive symptoms of ME/CFS), the answer might lie in the way the neuroinflammation affects neurotransmitters, particularly glutamate.
Activated microglia are known to secrete a large amount of glutamate via their glutamate transporters. Ref:
here.
And glutamate released from activated microglia down-regulates astrocyte glutamate transporters (whose function is to remove glutamate from the brain's extracellular spaces): this leads to the 'collusion' hypothesis for even further increases in extracellular glutamate in neuroinflammation. Ref:
here.
One
Japanese study determined that chronic microglial activation occurs in ME/CFS.
Chronic microglial activation has been
shown to be caused by persistent coxsackievirus B infections of the central nervous system (which are found in ME/CFS). Coxsackievirus B
can chronically infect astrocytes. Also, HHV-6 has the
ability infect astrocyte cells and dysregulate their glutamate clearance mechanisms.
Other diseases or conditions which involve chronic microglial activation include:
hepatitis C virus infection,
Lyme neuroborreliosis,
systemic lupus erythematosus,
schizophrenia and
bipolar disorder.
Rönnbäck and Hansson hypothesized that one of the reasons IL-1β, TNF-α and IL-6 cause mental fatigue and cognitive dysfunction is because these cytokines impede the clearance of glutamate performed by astrocyte cells, leading to raised levels of extracellular glutamate in the brain, which they hypothesize may affect neurotransmission.
So although low-grade neuroinflammation may not do much in terms of observable physical effects on the brain, it may nevertheless still modify neurotransmitters in a way that creates mental or cognitive symptoms.